Risk of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis complicated with type 2 diabetes mellitus
Qing-hui ZHANG,Hao-ling SHI,Sen HOU,Yong SHI
DOI: https://doi.org/10.13507/j.issn.1674-3474.2015.01.026
2015-01-01
Abstract:Objective To study whether type 2 diabetes mellitus (T2DM) increases the incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV)-related cirrhosis.Methods The clinical data of 450 patients with HBV related cirrhosis were retrospectively analyzed,and were divided into control group (n=301) and HCC group (n=149).The clinical data and laboratory findings were collected and compared between two groups.The relationship of T2DM with HCC was investigated by logistic regression analysis.Results The incidence of T2DM (20.8％),the proportions of male patients (84.6 ％),smoking history (46.3 ％) and α-fetoprotein ＞ 400 μg/L (51.0 ％),and the levels of plasma glucose ((5.89±2.43) mmol/L),albumin ((34.7±6.1) g/L),glutamate pyruvate transaminase (56(35,95) u/L),gamma glutamyl transpeptidase (102(53,258) u/L) and total bilirubin (16(8,33) μmol/L) in HCC group were significantly different from those in control group (31.9％,66.8％,32.6％,4.3％,(6.51±3.11) mmol/L,(31.9± 6.5) g/L,38(24,70) u/L,37(24,65) u/L) (P＜0.05,P＜0.01).Multivariableanalysis showed that the correlation factors of HCC in patients with HBV related cirrhosis were T2DM (OR 0.324,95％CI:0.173 to 0.805,P=0.010),α-fetoprotein ＞400μg/L (OR=22.385,95％CI:8.500 to 58.634,P=0.000),glutamate pyruvate transaminase (OR=0.993,95％CI:0.985 to 0.997,P=0.023),gamma glutamyl transpeptidase (OR=1.004,95％CI:1.000 to 1.007,P=0.039),total bilirubin (OR=1.017,95％CI:1.000 to 1.038,P=0.000) and albumin (OR=1.065,95％CI:1.005 to 1.135,P=0.046).Conclusion T2DM is correlated with HCC in patients with HBV related cirrhosis.